Related Experiment Videos
Rationale for combination antifungal therapy
1Department of Clinical Sciences and Administration, University of Houston College of Pharmacy Texas Medical Center, 77030-4095, USA.
Abstract:
The relentless increase of invasive fungal infections and poor outcomes associated with available antifungal agents prompted the search for better therapeutic strategies. Combining antifungal drugs was recommended as a means to enhance efficacy in a variety of invasive infections including cryptococcosis, candidiasis, and aspergillosis. With the exception of cryptococcal meningitis, data from controlled clinical trials supporting such combinations are sparse. Moreover, little consensus exists regarding which combinations are synergistic or antagonistic in vitro and in vivo. Based on available data, several principles underlie these combinations.
Insights
Antifungal drug combinations are explored to improve treatment for invasive fungal infections. However, clinical trial data supporting these combinations is limited, with ongoing debate about their effectiveness and interactions.
Area of Science:
- Mycology
- Infectious Diseases
- Pharmacology
Background:
- Rising incidence of invasive fungal infections necessitates improved therapeutic strategies.
- Current antifungal agents have limitations, leading to poor patient outcomes.
- Antifungal drug combinations are proposed to enhance efficacy against various fungal infections.
Purpose of the Study:
- To review the current state of evidence for antifungal drug combinations.
- To identify principles guiding the use of combination antifungal therapy.
- To address the lack of consensus on synergistic or antagonistic effects of these combinations.
Main Methods:
- Literature review of available data on antifungal drug combinations.
- Analysis of clinical trial data, where available.
- Assessment of in vitro and in vivo studies on drug interactions.
Main Results:
- Controlled clinical trial data supporting antifungal combinations is sparse, except for cryptococcal meningitis.
- Significant lack of consensus exists regarding the synergistic or antagonistic effects of various combinations.
- Several underlying principles for effective combination therapy have been identified based on existing data.
Conclusions:
- Combination antifungal therapy holds promise but requires more robust clinical validation.
- Further research is needed to establish optimal drug pairings and understand their interactions.
- Evidence-based guidelines are necessary to direct the clinical application of antifungal drug combinations.